Human Papillomavirus Vaccination

N Engl J Med. 2023 May 11;388(19):1790-1798. doi: 10.1056/NEJMcp2108502.

Authors

Lauri E Markowitz¹, Elizabeth R Unger¹

Affiliation

¹ From the Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (L.E.M.), and the Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (E.R.U.), Centers for Disease Control and Prevention, Atlanta.

PMID: 37163625
DOI: 10.1056/NEJMcp2108502

No abstract available

Publication types

Review

MeSH terms

Female
Human Papillomavirus Viruses
Humans
Immunization
Papillomavirus Infections* / complications
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / administration & dosage
Papillomavirus Vaccines* / adverse effects
Papillomavirus Vaccines* / therapeutic use
Uterine Cervical Neoplasms* / etiology
Uterine Cervical Neoplasms* / prevention & control
Uterine Cervical Neoplasms* / virology
Vaccination / adverse effects
Vaccination / methods

Substances

Papillomavirus Vaccines